Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001079973-25-001729
Filing Date
2025-11-14
Accepted
2025-11-14 08:14:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5990
  Complete submission text file 0001079973-25-001729.txt   7849
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Subject) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90044 | Film No.: 251481381
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301
Business Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301 927(0)779800501
S.H.N. Financial Investments Ltd. (Filed by) CIK: 0001890802 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A